Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saye Khoo

Showing results (251-260 of 282) with videos related to

Pageof 29
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 21, 2020
Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1Laura Dickinson, Stephen Walimbwa, Yashna Singh, et al.
Wellcome Open Research|April 4, 2022
TRUE-1: Trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults)Michael Abouyannis, Richard FitzGerald, Mwanajuma Ngama, et al.
Frontiers in Immunology|December 8, 2022
Short-term oral pre-exposure prophylaxis against HIV-1 modulates the transcriptome of foreskin tissue in young men in AfricaStefan Petkov, Carolina Herrera, Laura Else, et al.
Antimicrobial Agents and Chemotherapy|October 6, 2010
Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearanceAlessandro Schipani, Marco Siccardi, Antonio D'Avolio, et al.
Frontiers in Immunology|November 21, 2024
Gene expression of tight junctions in foreskin is not affected by HIV pre-exposure prophylaxisEmily L Webb, Stefan Petkov, Heejin Yun, et al.
AIDS (London, England)|December 1, 2021
Weight gain stopping/switch rules for antiretroviral clinical trialsW D Francois Venter, Simiso Sokhela, Alexandra Calmy, et al.
HIV Medicine|December 12, 2022
BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022Laura Waters, Alan Winston, Iain Reeves, et al.
Journal of the Pediatric Infectious Diseases Society|March 27, 2026
Brain Structure of South African Children Born to Mothers on Dolutegravir versus Efavirenz-Based Antiretroviral TherapyLayla E Bradford, Catherine J Wedderburn, Thokozile R Malaba, et al.
Ebiomedicine|February 28, 2025
Development of an oral regimen of unithiol for the treatment of snakebite envenoming: a phase 1 open-label dose-escalation safety trial and pharmacokinetic analysis in healthy Kenyan adultsMichael Abouyannis, Yvonne K Nyambura, Samson Ngome, et al.
Msphere|October 16, 2024
Optimization of SARS-CoV-2 culture from clinical samples for clinical trial applicationsDominic Wooding, Kate Buist, Alessandra Romero-Ramirez, et al.
Pageof 29

Showing results (251-260 of 282) with videos related to

Sort By:
Pageof 29
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 21, 2020
Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1Laura Dickinson, Stephen Walimbwa, Yashna Singh, et al.
Wellcome Open Research|April 4, 2022
TRUE-1: Trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults)Michael Abouyannis, Richard FitzGerald, Mwanajuma Ngama, et al.
Frontiers in Immunology|December 8, 2022
Short-term oral pre-exposure prophylaxis against HIV-1 modulates the transcriptome of foreskin tissue in young men in AfricaStefan Petkov, Carolina Herrera, Laura Else, et al.
Antimicrobial Agents and Chemotherapy|October 6, 2010
Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearanceAlessandro Schipani, Marco Siccardi, Antonio D'Avolio, et al.
Frontiers in Immunology|November 21, 2024
Gene expression of tight junctions in foreskin is not affected by HIV pre-exposure prophylaxisEmily L Webb, Stefan Petkov, Heejin Yun, et al.
AIDS (London, England)|December 1, 2021
Weight gain stopping/switch rules for antiretroviral clinical trialsW D Francois Venter, Simiso Sokhela, Alexandra Calmy, et al.
HIV Medicine|December 12, 2022
BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022Laura Waters, Alan Winston, Iain Reeves, et al.
Journal of the Pediatric Infectious Diseases Society|March 27, 2026
Brain Structure of South African Children Born to Mothers on Dolutegravir versus Efavirenz-Based Antiretroviral TherapyLayla E Bradford, Catherine J Wedderburn, Thokozile R Malaba, et al.
Ebiomedicine|February 28, 2025
Development of an oral regimen of unithiol for the treatment of snakebite envenoming: a phase 1 open-label dose-escalation safety trial and pharmacokinetic analysis in healthy Kenyan adultsMichael Abouyannis, Yvonne K Nyambura, Samson Ngome, et al.
Msphere|October 16, 2024
Optimization of SARS-CoV-2 culture from clinical samples for clinical trial applicationsDominic Wooding, Kate Buist, Alessandra Romero-Ramirez, et al.
Pageof 29